Because TXNDC9 expression was significantly increased in HCC, we sought to determine whether TXNDC9 expression according to the TMAs immunohistochemical staining results was associated with the clinicopathologic characteristics of HCC patients (Table 1). This evidence concerns the gene TXNDC9 and hepatocellular carcinoma.